Baylor College of Medicine in Houston has joined the organizing panel of the 10th annual World Stem Cell Summit (WSCS), set to be held between December 3rd and 5th, 2014 at the San Antonio Marriott Rivercenter in San Antonio, Texas. As an “Organizing Partner,” Baylor will join five other organizations that will develop the agenda of the WSCS, ten years after hosting the first edition of the event.
“GPI is delighted to partner again with Baylor College of Medicine to produce a Summit event. A decade ago, the first Summit was launched and Baylor College of Medicine served as our host institution. Pioneering heart surgeon and chancellor emeritus of Baylor, Dr. Michael DeBakey, provided the first keynote speech,” said Bernard Siegel, founder of the Summit and executive director of the Genetics Policy Institute (GPI).
The Senior Vice President for Research at Baylor College of Medicine, Dr. Adam Kuspa, also said that the college was very pleased to join the panel of organizers for the event. “Bernie Siegel and his colleagues have brought real vision and energy to this summit over the years, bringing together stakeholders in the application of stem cells from across the spectrum of research, industry, medical ethics, and health policy.”
The college was chosen given its reputation for being first in Texas in recieving funding from the National Institutes of Health, and home of the Stem Cells and Regenerative Medicine Center, or STaR, which focuses mainly on the study of both adult stem cells and embryonic stem cells. Current projects at BCM include investigating the role of tumor stem cells in cancer relapses — a project germane to the Summit.
“The field of stem cells and regenerative medicine has come a long way since then and it is fitting that Baylor College of Medicine, truly one of the world’s great biomedical research centers, is again partnering with us to produce our 10th anniversary Summit in Texas. The Texas Medical Center will again be well-represented at the World Stem Cell Summit, the premier interdisciplinary stem cell conference,” said Siegel.
The 10th annual meeting of the global stem cell community will focus on the progress made in regenerative medicine, and will gather the most recognized names in the field that to share research, build collaborations, and find solutions to funding and commercialization challenges. More than 200 speakers and panelists will discuss the acceleration of stem cell science and its translation to clinical trials and medical therapies for severe injury and diseases, such as the regeneration of tissues, organs and spinal cords, cancer, diabetes, neurological diseases, and heart disease.
“It is a propitious time for advancement in each of these domains given how dynamic the field has become over the past few years and as regenerative medicine emerges as a paradigm for new treatments of age-old diseases. Baylor College of Medicine remains committed to being a leader in the field and the World Stem Cell Summit serves as a wonderful platform to share our research and vision,” Adam Kuspa added.
The latest scientific discoveries, business models, translational issues, legal and regulatory solutions and best practices will be debated during the WSCS, which will include 200 sponsors, media partners, and endorsing organizations. It will also have other attractions besides the lectures, such as an exhibition hall, symposiums, networking receptions, the Genetics Policy Institute (GPI) Stem Cell Action Awards Dinner, a competitive Poster Forum, and the Conversations with Experts Luncheon.
The event is expected to attract more than 1,500 attendees, including not only researchers, but also industry leaders, clinicians, hospital administrators, regulators, philanthropists, economic development officers, journalists, lawyers and insurers, as well as patients looking for new treatments and cures, from 40 different countries.
In addition to Baylor, other organizing partners include the University of Texas Health Science Center at San Antonio, Genetics Policy Institute, Mayo Clinic, Kyoto University Institute for Integrated Cell-Material Sciences (iCeMS) and BioBridge Global, which are going to develop the agenda for the WSCS.
The co-chairs of the event will include Dr. Adam Kuspa (Baylor College of Medicine), Bernard Siegel (GPI), Dr. William L. Henrich (UT Health Science Center), Dr. Andre Terzic (Mayo Clinic), Professor Norio Nakatsuji (Kyoto University’s iCeMS) and Linda Myers (BioBridge Global).